Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Marta Robak"'
Publikováno v:
Diagnostyka Laboratoryjna. 57:188-194
Introduction: Contemporary technological development make the cytological analysis of megakaryocytes (MKs) a valuable tool for supporting differential diagnosis of myeloproliferative neoplasms’ (MPNs) early stages. Aim: The aim of the study was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5696499e639aea510c33540e71767061
https://doi.org/10.5604/01.3001.0016.0258
https://doi.org/10.5604/01.3001.0016.0258
Autor:
Paulina Stelmach, Weronika Nowak, Marta Robak, Emilia Krzemińska, Marzena Tybura-Sawicka, Krzysztof Chojnowski, Jacek Treliński
Publikováno v:
Acta Haematologica Polonica. 53:267-272
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f984633474145ca55f94e4d4537328c
https://doi.org/10.5603/ahp.a2022.0034
https://doi.org/10.5603/ahp.a2022.0034
Publikováno v:
Klinika Oczna. 123:24-29
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c2f582f12627c22f2ab333876edeeb2
https://doi.org/10.5114/ko.2021.102451
https://doi.org/10.5114/ko.2021.102451
Publikováno v:
Klinika Oczna. 122:165-170
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcb5d6551f9737953b2ec168fce103d6
https://doi.org/10.5114/ko.2020.101652
https://doi.org/10.5114/ko.2020.101652
Publikováno v:
Klinika Oczna. 122:112-116
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78c37756db58b2973f633d17bee07be1
https://doi.org/10.5114/ko.2020.97666
https://doi.org/10.5114/ko.2020.97666
Autor:
Ewelina Witkowska, Ewa Wawrzyniak, Agnieszka Wierzbowska, Katarzyna Jerzmanowska, Marta Robak, Agnieszka Pluta
Publikováno v:
Archives of Clinical and Medical Case Reports.
Acute myeloid leukemia (AML) is a heterogeneous clonal stem cell malignancy. Several subgroups of AML have been identified based on multiple genomic and proteomic aberrations; these demonstrate different clinical features, response to treatment and p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81fb0104639de887eeb011356c8ab131
https://doi.org/10.26502/acmcr.96550392
https://doi.org/10.26502/acmcr.96550392
Autor:
Krzysztof Chojnowski, Jacek Treliński, Katarzyna Bogusiak, Marta Robak, Aneta Neskoromna-Jędrzejczak
Publikováno v:
Acta Haematologica Polonica. 49:33-36
The preparation of patients with hemophilia before surgical operations and dental procedures constitutes a significant clinical challenge. This article presents the implantoprosthetic rehabilitation of a patient with severe hemophilia B (factor IX ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e38a72be23592ef2f84e00b621c89ba
https://doi.org/10.2478/ahp-2018-0006
https://doi.org/10.2478/ahp-2018-0006
Autor:
Katarzyna Pachniewska, Marta Robak, Krzysztof Chojnowski, Jacek Treliński, Justyna Matczak, Paweł Nowak
Publikováno v:
Advances in Clinical and Experimental Medicine. 25:1255-1263
BACKGROUND Congenital fibrinogen disorders (CFD) are rare fibrinogen deficiencies which may be quantitative or functional. The clinical course of hypofibrinogenemia (hypoFI) or dysfibrinogenemia (dysFI) is unpredictable and cannot be determined by th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5ebbb8b4f2dfc30fe07122c405edb3d
https://doi.org/10.17219/acem/65781
https://doi.org/10.17219/acem/65781
Publikováno v:
Transfusion. 56:2438-2442
BACKGROUND The treatment of patients with acute leukemia, who due to their religious beliefs refuse to accept blood transfusion, is a great challenge for hematologists. CASE REPORT We present a case of acute pre-T-lymphoblastic leukemia in a Jehovah'
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10dd1547547a162343d9ab32c93e9154
https://doi.org/10.1111/trf.13703
https://doi.org/10.1111/trf.13703
Publikováno v:
Advances in Clinical and Experimental Medicine. 24:995-1000
BACKGROUND Rivaroxaban (Xarelto) does not require routine coagulation monitoring; however, in certain clinical situations (overdose, drug accumulation, urgent surgery) measurement of its plasma concentration is highly recommended. Currently, there is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aa9280a7c0e188c587796ac753ac8fb
https://doi.org/10.17219/acem/42147
https://doi.org/10.17219/acem/42147